Legault Pierre's Form 4 filing
Syndax Pharmaceuticals Inc (SNDX) · filed Aug 9, 2022
- Accession no.
- 0001562180-22-005979
- Filed
- Aug 9, 2022
- Trade date
- Aug 5, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $552.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Legault PierreCIK 0001391045 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2022 | Common Stock | MOption exerciseAcquired | +10,000 | $9.63 | +$96,300 | 42,000 | Direct | |
| Aug 5, 2022 | Common Stock | SSaleDisposed | −10,000 | $23.02 | −$230,200 | 32,000 | Direct | |
| Aug 5, 2022 | Common Stock | MOption exerciseAcquired | +14,000 | $8.93 | +$125,020 | 46,000 | Direct | |
| Aug 5, 2022 | Common Stock | SSaleDisposed | −14,000 | $23.02 | −$322,280 | 32,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2022 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct | |
| Aug 5, 2022 | Common Stock | MOption exerciseDisposed | −14,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.